Kunming Pharmaceutical Corp.  

(Public, SHA:600422)   Watch this stock  
Find more results for 600422
+0.08 (0.29%)
Nov 19 - Close
SHA data delayed by 1 mins - Disclaimer
Currency in CNY
Range     -
52 week 19.80 - 31.99
Open     -
Vol. 0.00
Mkt cap 9.30B
P/E 33.95
EPS 0.80
Shares 341.13M
Oct 10, 2014
Kunming Pharmaceutical Corp Extraordinary Shareholders Meeting

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin 6.36% 6.57%
Operating margin 6.80% 7.42%
EBITD margin - 9.06%
Return on average assets 8.35% 9.36%
Return on average equity 12.21% 17.18%
Employees 3,386 -
CDP Score - -


+86-871-68319868 (Phone)
+86-871-68311968 (Fax)

Website links


Kunming Pharmaceutical Corp. is a China-based company principally engaged in manufacture, wholesaling and retailing of pharmaceuticals. The Company provides natural herbal medicines and chemical compound drugs, including drugs for central nervous systems, drugs for cardio and cerebral vascular diseases, anti-parasite drugs, antimicrobial drugs, anti-gout drugs, hormones and endocrine regulation drugs, drugs for hemorrhoids and anti-inflammatory drugs, among others. The Company also involves in pharmaceutical purchasing and distribution, as well as health supplements manufacturing. It distributes its products in domestic and overseas markets.

Officers and directors

Qin He Chairman of the Board
Age: 53
Pingdong Yuan President
Age: 44
Jiahong Lin Vice Chairman of the Board
Age: 43
Huijiang Liu Vice Chairman of the Board
Age: 57
Shaoquan Wang Chief Financial Officer
Age: 45
Chaoneng Xu Vice President, Secretary of the Board
Age: 49
Shaoyu Dong Vice President
Age: 56
Zhongzhan Lin Vice President
Age: 44
Peng Liu Vice President
Age: 49
Rong Pei Director
Age: 42